Fountain Life Kicks Off Its Involvement in Lake Nona by Joining a Group of Global Thought Leaders at This Year's Lake Nona Impact Forum
March 01, 2022 11:00 ET
|
Fountain Life
NAPLES, Fla., March 01, 2022 (GLOBE NEWSWIRE) -- The leadership at Fountain Life - a preventative health and longevity company committed to democratizing, digitizing, and demonetizing healthcare...
Avricore Health CEO Hosts Investor Call December 15th
December 09, 2021 13:51 ET
|
Avricore Health Inc.
VANCOUVER, British Columbia, Dec. 09, 2021 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) will host a year end update and look ahead discussion by the Company’s CEO...
Amydis Announces Successful Completion of a Pre-IND Meeting with the FDA for the Development of a First-in-Class Retinal Tracer Targeting TDP43 for the Diagnosis of ALS
December 06, 2021 07:00 ET
|
Amydis, Inc.
SAN DIEGO, Dec. 06, 2021 (GLOBE NEWSWIRE) -- Amydis Inc., a biotechnology company developing novel ocular contrast agents (“tracers”) targeting CNS biomarkers in the eye, today announced the...
EDRN's Pancreatic Cancer Detection Group Teams With Rhino Health to Leverage Federated Learning and Accelerate Medical Research
November 23, 2021 09:00 ET
|
Rhino HealthTech, Inc.
BOSTON, Nov. 23, 2021 (GLOBE NEWSWIRE) -- Rhino Health today announced a pilot project with the pancreatic cancer working group of the National Cancer Institute's Early Detection Research Network...
HealthTab™ Expands to British Columbia in Select Shoppers Drug Mart® Locations
October 26, 2021 08:00 ET
|
Avricore Health Inc.
VANCOUVER, British Columbia, Oct. 26, 2021 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) announces that it has expanded patient testing with the HealthTab™ platform...
Amydis Awarded $3 Million NIH Grant to Explore Novel Alpha Synuclein Retinal Tracer in Non-human Primate Models of Parkinson’s Disease and Multiple System Atrophy
October 11, 2021 07:00 ET
|
Amydis, Inc.
SAN DIEGO, Oct. 11, 2021 (GLOBE NEWSWIRE) -- Amydis Inc., a leading ocular tracer pharmaceutical company with a broad portfolio of diagnostic drug candidates targeting CNS biomarkers in the eye,...
Amydis Receives NIH Grant Award to Develop a Novel Tau Retinal Tracer for Alzheimer's Diseases and other Tauopathies
September 02, 2021 07:00 ET
|
Amydis, Inc.
SAN DIEGO, Sept. 02, 2021 (GLOBE NEWSWIRE) -- Amydis Inc., a leading ocular tracer pharmaceutical company with a broad portfolio of diagnostic drug candidates targeting CNS biomarkers in the eye,...
HealthTab™ Systems Deployed in Select Shoppers Drug Mart® Locations, Patient Testing Begins
August 10, 2021 05:00 ET
|
Avricore Health Inc.
VANCOUVER, British Columbia, Aug. 10, 2021 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) announces that patient testing has begun on the HealthTab™ platform in...
Avricore Health Partners with Ellerca Health Inc to Offer Joint Diabetes Screening and Management Support
July 28, 2021 09:55 ET
|
Avricore Health Inc.
VANCOUVER, British Columbia, July 28, 2021 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce it has signed a partnership...
HealthTab™ Adds ID Now™ Molecular Test Device to Abbott Distribution Agreement, Now Offers First Real-time Reporting of SARS-CoV-2, Flu, Strep and RSV System in Pharmacy
July 26, 2021 08:00 ET
|
Avricore Health Inc.
VANCOUVER, British Columbia, July 26, 2021 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce the signing of the first...